Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study

Published:2018-02-01 Issue:4 Volume:103 Page:698-706
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Michallet Anne-Sophie,Aktan Melih,Hiddemann Wolfgang,Ilhan Osman,Johansson Peter,Laribi Kamel,Meddeb Balkis,Moreno Carol,Raposo João,Schuh Anna,Ünal Ali,Widenius Tom,Bernhardt Alf,Kellershohn Kerstin,Messeri Dimitri,Osborne Stuart,Leblond Véronique

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety profile of first-line targeted therapies in elderly and/or comorbid chronic lymphocytic leukaemia patients (unfit subpopulation). A systematic review and network meta-analysis;Critical Reviews in Oncology/Hematology;2024-09

2. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024;Journal of the National Comprehensive Cancer Network;2024-04

3. Network meta-analysis of novel targeted therapies for relapsed/refractory chronic lymphocytic leukemia;Therapeutic Advances in Medical Oncology;2024-01

4. Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL;Blood;2023-09-28

5. Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update;Leukemia Research;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP